These echocardiographic parameters have associated with circulating cardiac biomarkers such as plasma A-, B-, and N-terminal pro-B-type natriuretic peptide (ANP, BNP, and NT-proBNP) which are commonly measured to diagnose and treat HF [7, 8]. Here, NPPA is linked to hydrops fetalis.